secwatch.observer — SEC 8-K summary
======================================

Issuer:     BBX Capital, Inc. (BBXIB)
CIK:        0001814974
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001437749-23-027968
Event type: debt
Sentiment:  negative
Materiality: 0.75
Item codes: 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BBX Capital's Renin subsidiary amends TD Bank facility, adds $1.25M equity, waives covenants through Dec 2023
--------------------------------------------------------------------------------

- Revolving credit line temporarily raised from $22M to $24.5M through Nov 2023, then steps down to $20M by Jan 2024.
- BBX Capital injected $1.25M to Renin, used to partially repay the term loan; Renin not compliant with some financial covenants.
- Total Leverage Ratio compliance waived for Q1-Q4 2023; new max 3.00x covenant begins Jan 1, 2024.
- Amendment fee of $15,000; equity injection is in addition to prior injections totaling over $36.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814974/000143774923027968/0001437749-23-027968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814974/000143774923027968/bbxi20231006_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-027968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer